Literature DB >> 3115427

Does nifedipine ameliorate cyclosporin A nephrotoxicity?

J Feehally1, J Walls, N Mistry, T Horsburgh, J Taylor, P S Veitch, P R Bell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3115427      PMCID： PMC1247150          DOI： 10.1136/bmj.295.6593.310

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  5 in total

1.  Nephrotoxicity of cyclosporin A. A lithium clearance and micropuncture study in rats.

Authors:  H Dieperink; P P Leyssac; H Starklint; E Kemp
Journal:  Eur J Clin Invest       Date:  1986-02       Impact factor: 4.686

2.  Antagonist capacities of nifedipine, captopril, phenoxybenzamine, prostacyclin and indomethacin on cyclosporin A induced impairment of rat renal function.

Authors:  H Dieperink; P P Leyssac; H Starklint; K A Jørgensen; E Kemp
Journal:  Eur J Clin Invest       Date:  1986-12       Impact factor: 4.686

3.  Cyclosporine-associated chronic nephropathy.

Authors:  B D Myers; J Ross; L Newton; J Luetscher; M Perlroth
Journal:  N Engl J Med       Date:  1984-09-13       Impact factor: 91.245

4.  Cyclosporine A--calcium channels interaction: a possible mechanism for nephrotoxicity.

Authors:  C N Nagineni; B C Misra; D B Lee; N Yanagawa
Journal:  Transplant Proc       Date:  1987-02       Impact factor: 1.066

5.  Cyclosporin in therapeutic doses increases renal allograft vascular resistance.

Authors:  J J Curtis; R G Luke; E Dubovsky; A G Diethelm; J D Whelchel; P Jones
Journal:  Lancet       Date:  1986-08-30       Impact factor: 79.321
  5 in total
  12 in total

1.  Influence of nicardipine on renal function and plasma cyclosporin in renal transplant patients.

Authors:  M Kessler; P Netter; E Renoult; B Jonon; J M Mur; P Trechot; B Dousset
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 2.  Thrombolytic treatment and new calcium antagonists.

Authors:  J Feely; T Pringle; D Maclean
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-05

Review 3.  Primary care of the renal transplant patient.

Authors:  J D Pirsch; R Friedman
Journal:  J Gen Intern Med       Date:  1994-01       Impact factor: 5.128

Review 4.  The pathophysiology of Sandimmune (cyclosporine) in man and animals.

Authors:  J Mason
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

5.  Nifedipine, verapamil and cyclosporin A pharmacokinetics in children.

Authors:  M R Ogborn; J F Crocker; P C Grimm
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

Review 6.  Prevention and management of the adverse effects associated with immunosuppressive therapy.

Authors:  S J Rossi; T J Schroeder; S Hariharan; M R First
Journal:  Drug Saf       Date:  1993-08       Impact factor: 5.606

7.  The interaction of the calcium channel blockers verapamil and nifedipine with cyclosporin A in pediatric renal transplant patients.

Authors:  J F Crocker; K W Renton; T L LeVatte; D H McLellan
Journal:  Pediatr Nephrol       Date:  1994-08       Impact factor: 3.714

Review 8.  Adverse reactions and interactions of cyclosporin.

Authors:  J P Scott; T W Higenbottam
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Mar-Apr

Review 9.  Do calcium channel blockers have renal protective effects?

Authors:  G P Reams
Journal:  Drugs Aging       Date:  1994-10       Impact factor: 3.923

10.  Nifedipine aggravates cyclosporine A-induced gingival hyperplasia.

Authors:  A Bökenkamp; B Bohnhorst; C Beier; N Albers; G Offner; J Brodehl
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.